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INTRODUCTION
Endocrine-disrupting chemicals (EDCs) are defined by the US
Environmental Protection Agency as a group of substances that
“interfere with biosynthesis, secretion, transport, elimination and
function of naturally existing hormones in the human body”.
Exposure to endocrine disruptors during crucial developmental
time windows increases an individual’s risk of developing a variety
of diseases, including inborn errors, infertility, obesity and cancer
(Crisp et al., 1998). One of the most well-known EDCs is
diethylstilbestrol (DES), a synthetic estrogen that was widely
prescribed in the 1940s-1970s to prevent miscarriage. During that
time period, millions of women and their offspring were exposed
to this compound, which was later shown to have teratogenic and
oncogenic effects on many organ systems especially the
reproductive tract (Ma, 2009). Since then, the mechanisms
underpinning DES-related pathogenesis have been intensively
studied and several animal models have been established
(McLachlan, 1977; McLachlan et al., 1980; Newbold and
McLachlan, 1982). The most widely used model for DES research
is the neonatal-DES model, which was first described by McLachlan
and co-workers in 1982 (Newbold and McLachlan, 1982). Female
mice receiving 1 mg/kg body weight/day of DES in the first 5 days
of their lives exhibited uterine malformations, including metaplasia
and reduced adenogenesis. These mice were overweight, subfertile
and developed uterine adenocarcinoma later in life (McLachlan et
al., 1982; Newbold and McLachlan, 1982; Newbold et al., 2007).
Although the mouse phenotypes do not fully recapitulate the
clinical findings (Hatch et al., 2001; Hoover et al., 2011), this model
is nonetheless valuable for understanding how EDCs impact
reproductive organ function in general. Notably, most of these DES
effects are mediated through the estrogen receptor  (ESR1), as
shown by the finding that Esr1-null mice are largely resistant to
DES-induced phenotypes (Couse et al., 2001).
The effect of DES on the uterus is of particular interest because
uterine metaplasia is one of the most common health problems for
women exposed to DES before birth (DES-daughters), which could
lead to infertility. The neonatal uterus is composed of a simple
columnar luminal epithelium, a fibroblast mesenchymal (stromal)
layer and smooth muscles. It is well known that stromal cells play
an inductive role in the differentiation of the uterine epithelium
(UE) during reproductive tract patterning (Cunha, 1972). We and
others have shown that the neonatal uterus is prone to DES-
mediated teratogenic effects, exhibiting marked morphological and
gene expression changes shortly after DES exposure (Huang et al.,
2005; Ma et al., 1998; Miller et al., 1998; Yin et al., 2008). A recent
study demonstrated that the uterine epithelial ESR1 is dispensible
for the proliferative response but is required for suppressing UE
apoptosis as well as lactoferrin induction, indicating both cell-
autonomous and non-cell-autonomous mechanisms in estrogen
signaling (Winuthayanon et al., 2010).
To better understand the dynamic regulation of uterine biology
by DES treatment, we performed tissue-specific cDNA microarray
analyses and discovered that DES-elicited gene expression changes
occurred mostly in the UE. A core group of genes involved in
adipogenesis and glucose metabolism, especially the CCAAT-
enhancer-binding proteins (C/EBPs) and peroxisome proliferator-
activated receptor  (PPAR), were induced by DES in the UE. We
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SUMMARY
Developmental exposure to diethylstilbestrol (DES) causes reproductive tract malformations, affects fertility and increases the risk of clear cell carcinoma
of the vagina and cervix in humans. Previous studies on a well-established mouse DES model demonstrated that it recapitulates many features of
the human syndrome, yet the underlying molecular mechanism is far from clear. Using the neonatal DES mouse model, the present study uses
global transcript profiling to systematically explore early gene expression changes in individual epithelial and mesenchymal compartments of the
neonatal uterus. Over 900 genes show differential expression upon DES treatment in either one or both tissue layers. Interestingly, multiple components
of peroxisome proliferator-activated receptor- (PPAR)-mediated adipogenesis and lipid metabolism, including PPAR itself, are targets of DES in
the neonatal uterus. Transmission electron microscopy and Oil-Red O staining further demonstrate a dramatic increase in lipid deposition in uterine
epithelial cells upon DES exposure. Neonatal DES exposure also perturbs glucose homeostasis in the uterine epithelium. Some of these neonatal
DES-induced metabolic changes appear to last into adulthood, suggesting a permanent effect of DES on energy metabolism in uterine epithelial
cells. This study extends the list of biological processes that can be regulated by estrogen or DES, and provides a novel perspective for endocrine
disruptor-induced reproductive abnormalities.
Neonatal diethylstilbestrol exposure alters the
metabolic profile of uterine epithelial cells
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further demonstrated that activation of PPAR was essential for
initiation of abnormal adipogenesis in UE cells. This work
implicates the adipogenic program as a downstream target of DES
in the UE, which leads to the hypothesis that DES and possibly
other EDCs might activate similar genetic pathways in other
estrogen-responsive tissues, especially the adipocytes, to cause
adulthood obesity.
RESULTS
Neonatal DES exposure alters uterine cell metabolism
predominantly in the epithelium
The prevailing hypothesis is that the reproductive pathology in
DES-daughters is defined by transient molecular changes during
the crucial developmental period when DES is administrated. To
reveal potential mechanisms involved in this complex process, we
sought to capture early DES-induced gene expression changes in
the UE and uterine mesenchyme (UM) using cDNA microarray
analyses. We separated UE from the UM from vehicle (oil)- or DES-
treated postnatal day 5 (P5) mice, and prepared biological triplicates
of RNA from pooled specimens (n≥3). Those samples were
analyzed on two MouseWG-6 BeadChips, which detects 45,200
transcripts, including more than 26,000 annotated genes in the
NCBI RefSeq database. A difference of at least twofold in signal
intensity of each given probe set with a P value less than 0.05 was
considered statistically significant. As a result of this analysis, 981
transcripts were found differentially expressed in the UE, UM or
both between oil- and DES-treated groups (supplementary material
Table S1 and the Gene Expression Omnibus, GEO# GSE37969).
Hierarchical clustering analysis showed that among these
differentially regulated genes (DRGs), the majority (80%) were either
changed exclusively in the UE or showed a more prominent
dysregulation in the UE (Fig. 1A, red boxes). Around 10% of the
DRGs were similarly regulated in both tissue layers, and another
10% showed altered gene expression in the UM alone (Fig. 1A, green
and black boxes, respectively). When plotted on a log2-scaled star
glyph, it is obvious that the fold-changes of most DRGs were more
pronounced in the UE, either up- or downregulated (Fig. 1B). The
number of DRGs is summarized in Fig. 1C, which further
demonstrates that the UE contains more unique DRGs compared
with the UM. The UE-specific DRGs were further analyzed and
categorized by their biological functions following the criteria of
the Gene Ontology Consortium. Genes involved in metabolism
accounted for the largest proportion of the DRGs (16.7%), followed
by those regulating cell growth and maintenance (12.5%), cell
communication (10.1%) and signal transduction (8.1%; Fig. 1D;
supplementary material Table S2). These results indicated that
neonatal DES treatment affected biology of the UE more than it
did the UM, even though the UE expresses only marginal levels of
estrogen receptor-, the key mediator of DES action (Korach et
al., 1988).
Neonatal DES exposure alters adipogenesis and lipid metabolism
in the UE
Further analysis of the 213 DRGs involved in metabolic regulation
according to the KEGG (Kyoto Encyclopedia of Genes and
Genomes) pathway database showed that metabolism of complex
lipids was the most affected cellular metabolic pathways
(supplementary material Table S3) (Kanehisa et al., 2006). Careful
examination of genes involved in fatty acid transport and
metabolism showed that many were expressed abnormally in the
UE (Fig. 2A, red boxes). Ppar, a gene encoding the key regulator
of adipocyte differenctiation, insulin sensitivity, inflammation and
the endocrine signaling pathway (Barak et al., 1999; Fischer-
Posovszky et al., 2007; Tontonoz et al., 1994), showed marked
upregulation in DES-treated UE in our microarray. We further
verified this result using quantitative real-time reverse
transcription-polymerase chain reaction (RT-PCR), and
confirmed a tenfold upregulation in DES-treated UE (Fig. 2B).
Furthermore, both western blotting and immunohistochemistry
clearly demonstrated elevated PPAR protein levels in DES-
treated UE (Fig. 2C-E). PPAR is a nuclear hormone receptor that
belongs to the peroxisome proliferator-activated receptor gene
family. Both natural ligands, such as unsaturated fatty acids, and
synthetic ligands, such as thiazolidinediones (TZDs), can activate
PPAR (Lehmann et al., 1995). Once activated, cytoplasmic
PPAR translocates into the nucleus where it heterodimerizes with
retinoid X receptor (RXR), and directly regulates gene
transcription by binding to PPAR-response elements (PPREs)
through its DNA binding domain. Consistent with the observed
upregulation of PPAR expression, many known PPAR
transcriptional targets, including Gpr109a, Acsl1, Rarb and Arnt1
(Inoue et al., 2005; James et al., 2003; Jeninga et al., 2009; Karnik
et al., 2009), also showed marked changes in expression upon DES
treatment in the UE (Fig. 2B). Notably, the expressions of these
genes were either low or unchanged in the UM, which is consistent
with a cell-autonomous role for PPAR in mediating
transcriptional regulation. Collectively, these data suggest that the
PPAR signaling cascade is abnormally activated in the UE by
neonatal DES treatment in the mouse.
In addition to the PPAR pathway, expressions of many other
genes implicated in adipocyte differentiation were also perturbed
by DES exposure. Besides PPARs, C/EBPs are the other crucial
factors regulating preadipocyte differentiation. It is well established
that preadipocyte differentiation starts with activation of C/EBP
and C/EBP, followed by activation of C/EBP and PPAR (Wu et
al., 1996; Yeh et al., 1995). This process is positively regulated by
transcription factors Krüppel-like factor 4 (KLF4), KLF6, early
growth response gene 2 (EGR2), and negatively regulated by
transmembrane proto-oncogene Delta-like 1 (DLK1) (Birsoy et al.,
2008; Boyle et al., 2009; Li et al., 2005). Interestingly, we detected
a significant increase in expression of aforementioned positive
regulators, including Cebpa, Cebpb, Klf4, Klf6 and Egr2 in the UE
by quantitative RT-PCR analyses (Fig. 2A,B). Accumulation of
nuclear KLF4 protein was also evident by immunofluorescence (Fig.
2F,G). By contrast, expression of the negative regulator Dlk1 was
decreased by DES in the UE (Fig. 2B). These data suggest that the
core transcriptional cascade favoring adipogenesis is ectopically
switched on in the luminal epithelial cells of the neonatal uterus
by DES treatment.
Possibly as a result of this ectopic activation of the adipogenic
signaling pathway, expressions of many genes involved in lipid
metabolism were also altered. As shown in Fig. 2A,H, the expression
of long-chain fatty acid transport protein 1, encoded by Slc27a1,
was dramatically increased in the luminal epithelium by DES
treatment. Similarly, the expression of Slc27a2, which encodes fatty
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treatment. Moreover, the expression of Agpat1, a gene encoding
an acyltransferase that converts phospholipid lysophosphatidic acid
(LPA) into phosphatidic acid (PA), and that of Dgat2, a gene
encoding diglyceride acyltransferase that catalyzes the formation
of triglycerides from diacylglycerol and Acyl-CoA, were both
upregulated in the UE (Fig. 2H). On the other hand, the gene
encoding phospholipid transfer protein (Pltp) was significantly
downregulated in the UE. Taken together, these data suggest that,
in addition to turning on the lipogenic signaling cascades, neonatal
DES treatment also alters expression of genes responsible for lipid
transport and metabolism in UE cells.
DES induces PPAR-dependent adipogenesis in the UE
Our gene profiling and subsequent analyses indicated that ectopic
adipogenesis is induced by DES in UE cells, which prompted us to
evaluate the ultrastructure of the UE for evidence of adipogenesis.
Transmission electron microscopy (TEM) on ultra-thin sections
of P5 uterus revealed many conspicuous, electron-dense droplets
located close to the basal side of DES-treated UE cells, which were
rarely detected in control UE (Fig. 3A,B, arrows). As the
morphology of these droplets resembles lipid droplets observed in
many adipocytes, we stained frozen uterine sections with Oil-Red
O (ORO), a lysochrome diazo dye that binds neutral lipids. Normal
Fig. 1. DES alters uterine gene expression primarily in the epithelium. (A)Hierarchical clustering heatmap of differentially regulated genes by DES in the UE
and UM. Green to red, color range gradient of mean abundance (−0.7 to 0.7). Each column represents a pool of more than three animals. Red box, genes whose
expression was altered by DES primarily in the UE; green box, genes regulated by DES similarly in the UE and UM; black box, genes altered by DES primarily in the
UM. (B)Star glyph distribution of the fold-change of differentially regulated gene in the uterus; log2 values of the mean fold-change. Red, UM; blue, UE. (C)Venn
diagram of UE and UM DRGs. (D)Pie chart showing classification of DRGs based on Gene Ontology Consortium biological processes. Note that some genes
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uterus at P5 did not stain for ORO; however, prominent ORO-
staining was evident in DES-treated luminal epithelial cells close
to the basement membrane, which coincides with the abundant
droplets seen by TEM (Fig. 3E,F, arrows). These data demonstrate
that in merely 5 days, DES transiently activated the adipogenic
program in the UE, rendering them lipogenic.
Because PPAR is considered the key modulator of adipogenesis,
we tested the hypothesis that DES-induced lipogenic effects are
mediated through PPAR. We pooled neonatal female mice into
four groups which received oil, DES, or DES in combination with
PPAR inhibitors GW9662 or BADGE, and examined their uteri
at P5. Indeed, co-treatment with either inhibitor attenuated DES-
induced lipid accumulation in the UE, resulting in a significantly
reduced number of lipid droplets (Fig.3C,D,G,H,I) (oil, 0.25±0.16;
DES, 6.91±1.15; GW+DES, 2.32±0.80; BADGE+DES, 1.90±0.57
droplets/m; *P<1×10–4). In addition, combined treatments also
reduced the size of the residual lipid droplets (Fig. 3C,D,I). When
neonatal mice received five daily injections of Pioglitazone, a TZD-
class PPAR agonist that selectively stimulates PPAR activity, lipid
droplet accumulation was evident in the UE (Fig. 3J). Interestingly,
these droplets were present throughout the UE with no subcellular
confinement (Fig. 3J, inset, arrowheads). When DES was co-
injected with TZD, however, intense ORO staining was detected
only on the basal side of the UE (Fig. 3K, arrows, compare with
3F,J). Taken together, these data clearly demonstrated that PPAR,
induced by neonatal DES exposure, is both necessary and sufficient
to cause aggregation of lipid droplets in the UE. Moreover, DES
not only upregulates PPAR expression but must also increase
endogenous PPAR ligand expression and accumulation in the UE
to ectopically activate this program. On the other hand, genes
involved in lipid trafficking must also be affected by DES to elicit
the distinct basally-localized lipid droplet phenotype in the UE.
Fig. 2. DES affects lipid metabolism and transport. (A)Hierarchical clustering heatmap of genes involved in lipid trafficking and metabolism. Green to red,
color range gradient of mean abundance (−1.0 to 1.0). Red box, genes whose expression was altered by DES primarily in the UE. (B)Real-time RT-PCR survey of
genes involved in adipocyte differentiation in the uterus. Expression of each gene was normalized to that of Rpl7; normalized expression by oil UE was
considered to be 1.0. (C)Western blot on whole uterine lysates showed markedly increased PPAR protein in DES-treated uteri. GAPDH served as a loading
control. (D,E)Immunohistochemistry of PPAR showed increased staining in the DES-treated UE. Inset shows that PPAR was predominantly detected in the UE
nuclei (arrow). (F,G)Increased KLF4 protein was detected in the UE nuclei by immunofluorescence. Red, KLF4; blue, nuclei. Insets show magnified
immunofluorescence signal of the boxed region. (H)Real-time RT-PCR validated genes involved in fatty acid transport and metabolism in oil- or DES-treated UE
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Neonatal DES exposure alters glucose transport and metabolism
in the UE
In addition to lipid metabolism, carbohydrate metabolism was also
strongly affected by DES treatment. The expression of Slc2a1, which
encodes facilitated glucose transporter 1 (also known as GLUT1),
was upregulated 4.5-fold in the UE (supplementary material Table
S1). Immunofluorescence revealed that GLUT1 was expressed in
the cytoplasm of UE cells at low levels under normal conditions,
but was dramatically induced and translocated to the basal-lateral
membrane of the UE cells upon DES exposure (Fig. 4A,B, insets).
This rapid increase and translocation of GLUT1 could facilitate
glucose uptake by the UE cells from the extracellular matrix. To
test whether this is the case, we isolated UE from oil- and DES-
treated P5 female pups and performed glucose uptake assays on
suspended epithelial cells. In support of our hypothesis, DES-
treated UE cells showed a marked increase in their ability to
transport free D-glucose in solution (Fig. 4G). Enhanced glucose
uptake probably leads to increased conversion from glucose to
glucose-6-phosphate and stimulates subsequent glycolysis or other
alternative pathways. We therefore analyzed the expression of
crucial enzymes regulating this metabolic pathway in oil- and DES-
treated uterine samples. We found that hexokinase 2 (HK2), a low-
Km glycolytic enzyme converting glucose to glucose-6-phosphate,
showed a 3.7-fold upregulation in DES-treated UE by our
microarray (supplementary material Table S1).
Immunofluorescence analysis further revealed that HK2 expression
in the UE was strongly upregulated by DES, compared with that
in controls (Fig. 4C,D). Similarly, our microarray results
demonstrated a 2.8-fold increase in transcript level of X-linked G
glucose-6-phosphate dehydrogenase (G6pdx), an enzyme involved
in the first step of pentose phosphate pathway (PPP). This increase
was also confirmed by immunofluorescence (Fig. 4E,F;
supplementary material Table S1). Elevated protein expression of
HK2 and G6PD was further confirmed by western blot (Fig. 4H).
Taken together, these data demonstrated an overt effect of DES on
carbohydrate homeostasis of the UE cells.
Neonatal DES exposure alters metabolic pathways in adult UE
To determine the long-term effects of neonatal DES exposure, we
evaluated UE cell metabolism in adult female mice neonatally
exposed to DES. Neonatally treated mice were ovariectomized,
received a single injection of either oil, DES or 17-estrodial (E2)
at 10 weeks of age, and their uteri examined 24 hours later. ORO
staining showed sporadic lipid droplets in neonatally DES-treated
uteri, whereas none was detected in controls (Fig. 5A,D, arrows).
On the other hand, one dose of DES was sufficient to cause lipid
droplet accumulation in adult UE after merely 24 hours, regardless
of their neonatal exposure status (Fig. 5B,E). It is noteworthy that
Fig. 3. DES-induced lipogenesis in UE is mediated through PPAR. (A-D)TEM of UE at P5 revealed that DES treatment alone caused accumulation of electron-
dense droplets in the UE close to the basement membrane (B, arrows, compare with A). Co-injection of PPAR inhibitor BADGE (C) or GW9662 (D) dampened this
effect, resulting in a lower number of droplets. (E-H)ORO staining identified droplets as neutral lipid droplets (F) and confirmed that co-treatment of DES with
PPAR inhibitors severely attenuated this effect (G,H). (I)Quantification of lipid droplets from TEM images confirmed DES-induced accumulation of lipid droplets
in the UE. Co-treatment of DES with PPAR inhibitors resulted in reduced number and size of the droplets. *P<1×10–4. (J)PPAR agonist pioglitazone (TZD)
induced lipid droplet formation in the UE without specific subcellular localization (arrowheads). (K)Co-injection of TZD and DES resulted in intense ORO staining
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this change was confined to the luminal epithelium, but was not
seen in the glandular epithelium (Fig. 5B, arrowhead). Intriguingly,
E2 treatment at physiological concentration (100 ng) readily
induced lipid droplet formation in the UE previously exposed to
DES but had minimal effect on the control UE (Fig. 5C,F).
Concordantly, Ppar expression was induced by DES in both
neonatally oil- or DES-treated uteri, but its induction by E2 was
observed only in the neonatally DES-treated uterus (supplementary
material Fig. S1). On the other hand, G6PD was expressed at a much
higher level in the neonatally DES-treated adult UE than in controls
(Fig. 5J, compare with 5G).  Similarly, GLUT1 expression was
elevated in the UE of adults treated neonatally with DES
(supplementary material Fig. S1B,C). DES or E2 treatment in adults
did not significantly affect the expression of either gene in the uterus
(Fig. 5H,I,K,L and data not shown). Collectively these results
indicate that neonatal DES exposure has a permanent effect on lipid
and glucose homeostasis in the adult UE. 
DISCUSSION
Ever since the discovery of the adverse effects of DES on human
reproductive organs, great efforts have been invested in elucidating
the molecular mechanisms leading to these detrimental defects.
The neonatal mouse DES model is an excellent model because adult
mice exposed to DES at an early developmental stage present many
phenotypic resemblances to human DES-sons and DES-daughters.
Neonatal DES exposure alters the expression of essential
developmental regulators such as Wnt and Hox genes during the
crucial period of uterine differentiation (Ma et al., 1998; Miller et
al., 1998). It is our hypothesis that the transient gene expression
perturbation caused by neonatal DES treatment can permanently
alter uterine cell physiology and thus prime the UE for future
pathogenesis. Previously, our group has conducted gene expression
profiling experiments on neonatal mouse uterus exposed to DES
and uncovered 427 differentially expressed genes, including those
involved in cell proliferation, apoptosis and differentiation (Huang
et al., 2005). However, mRNA used in this analysis was extracted
from the whole uterus, a morphologically heterogeneous tissue,
which did not reveal tissue-specific gene regulation. To resolve this
issue, we employed a combined enzymatic and mechanical method
modified from the protocol introduced by the Cunha group to
isolate UE from the underlying UM (Bigsby et al., 1986). This
approach allowed us to determine the effect of DES on distinct cell
types and to identify target genes in a tissue-specific manner. Our
current microarray data revealed 981 differentially regulated genes
in the uterus, which is many more than found in our previous study
using the whole uterus (Huang et al., 2005). This increase in the
number of DRGs could be the result of different array platforms
used in the two studies. Alternatively, using the whole uterus could
have masked any expression changes that occurred only in one
tissue compartment and rendered the changes not statistically
significant.
Among the 981 DRGs, the majority of them were either specific
to the UE or showed a more prominent fold-change in the UE. It
is believed that DES exerts its function mainly through binding to
the estrogen receptors (ERs or ESRs), and Esr1-null females showed
complete resistance to the long-term effects of neonatal DES (Couse
et al., 2001). Because ESR1 is expressed primarily in the UM at
postnatal day 4-5 (Korach et al., 1988), it was surprising that the
UE is more readily responsive than the UM to DES exposure and
showed a myriad of gene expression changes. One possible
explanation is that the ER signaling pathway is more robust in the
UE than in the UM. For example, the ER co-activators might be
differentially expressed in the two tissue compartments. To support
this notion, we examined the expression of known ER co-
activators in our array and found that two co-activators, Ada and
PBP, were expressed at higher levels in the UE than in the UM
(GEO# GSE37969). A second possibility is that some epithelial gene
expression changes are secondary to altered stromal signaling
because the UE is plastic and receives instructive signals from the
UM at this stage of development (Cunha, 1976). In this scenario,
DES induces primary gene expression changes in the UM, which
subsequently causes more dramatic changes in UE gene expression
through paracrine signaling. Thirdly, our microarray data indicates
Fig. 4. DES alters glucose transport and metabolism in the UE.
(A,B)Immunofluorescence against GLUT1 showed a dramatic increase and
translocation to the basal-lateral membrane of the protein upon DES
treatment. (C-F)Immunofluorescence of HK2 (C,D) and G6PD (E,F) revealed
that both were expressed at low levels in the UE at P5, but were markedly
upregulated by neonatal DES treatment. Insets show magnified
immunofluorescence signal of the boxed area in each panel. (G)Glucose
uptake assay showed a 1.4-fold increase in isolated DES-treated UE compared
with controls. **P<0.025. (H)Western blot of HK2 and G6PD confirmed their
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that DES exclusively induces Esr1 expression in the UE but not in
the UM (GEO# GSE37969), which might contribute to increased
ESR signaling in the UE. Finally, it is also possible that, in addition
to ESRs, other steroid hormone receptor(s) transduce DES signaling
in UE cells. One such candidate is the orphan nuclear receptor
estrogen-receptor-related receptors (ERR, ERR and ERR),
previously reported to interact with DES, which suppresses co-
activator binding and affects transcription of downstream targets
in trophoblast cells (Tremblay et al., 2001). We found in our
microarray that Esrra, which encodes ERR, was highly expressed
in the UE, and was upregulated 2.8-fold (P0.00047) by DES
treatment. On the other hand, its expression was low in the UM
and unaffected by DES (supplementary material Table S1 and GEO#
GSE37969).
The most interesting finding in our study was the ectopic
accumulation of lipid droplets in the UE, as evidenced by both
ultrastructural and histological analyses. This abnormal activation
of adipogenesis results from aberrant lipid metabolism and
trafficking in the UE upon DES exposure. As a consequence of the
altered lipid metabolism, UE cells might use alternative metabolic
pathways for energy storage and/or consumption, which could lead
to undesired epigenetic changes (Wellen et al., 2009) and cause
disease later in life. Thus, this abnormal adipogenesis could also
be a potential mechanism that contributes to the etiology of DES-
induced uterine metaplasia.
Previous studies have reported that estrogen treatment in adult
mice resulted in increased lipid biosynthesis (Bourke et al., 1991;
Stacey et al., 1991). In this study we provide additional mechanistic
insights into this process by both gene profiling experiments and
functional analyses. The program of adipocyte differentiation is
tightly regulated through a genetic cascade mainly involving
sequential activation of C/EBP and C/EBP, followed by PPAR
and C/EBP (Tontonoz et al., 1994). We found that DES ectopically
activated the adipogenic program by affecting the expression of
both positive and negative regulators of this pathway. Activation
of PPAR is a crucial event in this process, as clearly demonstrated
Fig. 5. Neonatal DES treatment alters adult UE metabolic homeostasis. (A-F)ORO staining of uteri of ovariectomized (OVX) adult mice. No staining was
detected in the OVX UE of control animals (A), whereas a number of lipid droplets were observed in the OVX UE neonatally exposed to DES (D, arrows). Dashed
lines outline the UE. DES induced ORO staining in the luminal UE of both groups (B,E, arrows), without affecting the glandular epithelium (B, arrowhead). E2
treatment induced ORO staining in the UE of animals previously exposed to DES (F, arrow), but had little effect on neonatally oil-treated UE (C). (G-L)Expression
of G6PD assessed by immunofluorescence. G6PD was higher in the UE with neonatal DES exposure (J) and remained high when treated with DES or E2 (K,L).
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by antagonist and agonist experiments showing that it is both
necessary and sufficient to induce ectopic lipid droplet formation
in the UE. The exact mechanism through which DES activates
PPAR is still not clear, although a previous study suggested that
PPAR could be regulated by ovarian hormones during
implantation (Li et al., 2004). We found that elevation of Ppar
transcript was not observed until 18 hours after DES treatment
(data not shown), suggesting that its regulation by DES might be
secondary and mediated by other upstream factors. One such
candidate is C/EBP, which is a known activator of PPAR in 3T3-
L1 adipocytes and has previously been shown to be a direct target
of 17-estradiol in the adult mouse uterus (Gellersen et al., 2010).
The subcellular localization of DES-induced lipid droplets, however,
cannot be achieved by activating PPAR alone (Fig. 3J), indicating
that other lipid-interacting molecules must also be induced to
contribute to this phenotype.
PPAR has two isoforms in the mouse resulting from alternative
usage of 5 exons (Tontonoz et al., 1994; Zhu et al., 1995). PPAR1
is expressed ubiquitously at low levels whereas PPAR2 is highly
expressed in the adipose tissue and large intestine (Mansen et al.,
1996; Tontonoz et al., 1994). PPAR1 is induced by DES in neonatal
uterus, but is suppressed in abdominal fat pad (supplementary
material Fig. S2B). By contrast, PPAR2 is absent in the uterus but
induced by DES in the fat pad (supplementary material Fig. S2B).
These results indicate tissue-specific regulation of Ppar isoforms
by DES. Recent epidemiological studies indicate that exposure to
EDCs during early development is associated with overweight,
obesity and type 2 diabetes later on (Gladen et al., 2000; Goncharov
et al., 2008; Smink et al., 2008; Vasiliu et al., 2006). Other than its
adverse effects on the reproductive tract, neonatal DES exposure
also leads to the development of obesity in adult animals as young
as 2 months of age and throughout adulthood (Newbold et al.,
2007). Newbold et al. clearly showed that all white fat depots
weighed more in DES-treated mice than in controls, especially the
inguinal and retroperitoneal fat pads, whereas brown fat depot
weights were not affected. This DES-induced weight gain is ESR1-
dependent (Couse et al., 2000). The fact that ESR1 is only expressed
in white but not brown adipocytes (Rodriguez-Cuenca et al., 2005)
is sufficient to explain the differential response of white and brown
adipose tissues to neonatal DES treatment. We speculate that
neonatal DES exposure might also activate the adipogenic program
through ESR1 in mesenchymal cells, leading to an increased
number of adipocytes at an early age. Indeed, we showed that as
early as P5, increased Ppar2 transcript and PPAR protein were
evident in the abdominal fat pad (white adipose tissue) of mice
exposed neonatally to DES (supplementary material Fig. S2B,C).
Future investigations addressing molecular changes in fat tissues
in DES-treated mice will further our understandings on how DES,
and possibly other EDCs, cause obesity and other related diseases.
Lipogenesis and glycolysis are two closely regulated processes
sharing common intermediate metabolites such as
dihydroxyacetone phosphate (DHAP), which is generated by
glycolysis and serves as a main source of glycerol backbone for
lipogenesis. Thus, perturbation of one process often affects the
other. We observed altered glucose homeostasis in DES-treated UE,
including elevated GLUT1 expression and enhanced glucose
transport. These findings are in line with previous reports that
estradiol alters glucose transporter expression and glucose uptake
in adult mouse and pre-pubertal rat uteri (Kim and Moley, 2009;
Welch and Gorski, 1999). In addition, we found that several key
enzymes involved in glycolysis, including HK2, ALDO1 and PGK1,
are all upregulated in UE cells by DES (Fig. 4 and data not shown).
Abnormal glucose metabolism in the UE is also evidenced by the
abnormal expression of enzymes involved in the PPP: G6PD, the
enzyme responsible for the first and rate-limiting step of PPP, is
strongly activated in the UE (Fig. 4). Notably, utilization of PPP
leads to production of NADPH, which provides the reducing power
needed in cellular biosynthesis, particularly lipogenesis (Chascione
et al., 1987). Whether the PPP is the preferred choice of glucose
metabolism in DES-treated UE cells requires further investigation.
Our findings also indicate that neonatal DES exposure has a long-
lasting effect on UE metabolism. We observed a higher number of
lipid droplets in ovariectomized adult UE neonatally exposed to
DES, as well as increased G6PD and GLUT1 expression. These data
suggest that DES elicited permanent changes in gene expression,
which was independent of ovarian hormones. Moreover, neonatal
DES exposure altered adult UE response to estrogens, as evidenced
by lipid droplet accumulation as well as molecular markers.
Previously Newbold and co-workers reported that a high dose of
neonatal DES treatment desensitized uterine responsiveness to E2
in juvenile mice, as measured by uterine weight gains (Newbold et
al., 2004). By contrast, we found that early DES exposure renders
the adult uterus more sensitive to E2-induced lipid droplet
formation as well as to some gene expressions (PPAR). On the
other hand, neonatal DES dampened the E2 regulation of Arntl
expression (supplementary material Fig. S1A). Therefore, early DES
exposure leads to a more complex and pleiotropic estrogenic
responsiveness in the adult uterus. It is likely that epigenetic changes
caused by DES are the underlying mechanism for the long-term
effects of DES.
In summary, we have demonstrated that neonatal DES treatment
dramatically alters the metabolic pathways in UE cells. It is not clear
at this point whether the mouse DES phenotype is relevant to
clinical findings; nevertheless, our observations provide a novel
mechanism through which DES, and possibly other EDCs, can
affect homeostasis of the female reproductive tract.
METHODS
Mice
All mice were housed in the animal facility at Washington
University with controlled light and dark cycles and handled in
accordance with National Institutes of Health guidelines. All
procedures were approved by the Washington University
Institutional Animal and Use Committee. Time-pregnant CD-1
mice were purchased from Charles River Breeding Laboratory
(Wilmington, MA). DES was prepared and injected subcutaneously
into female pups from P1 to P5 as described previously (Huang et
al., 2005). PPAR inhibitors bisphenol A diglycidyl ether (BADGE)
and GW9662 were purchased from Sigma-Aldrich (St Louis, MO).
Stock solution (50×) was prepared in DMSO at a concentration of
150 mg/ml for BADGE and 10 mg/ml for GW9662. Working
solutions were made fresh in sterile PBS on the day of injection.
PPAR inhibitor was administered daily intraperitoneally at a
concentration of 30 mg/kg for BADGE (Naveiras et al., 2009) or 2
mg/kg for GW9662 (De Backer et al., 2009). PPAR agonist
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solution and injected subcutaneously (20 mg/kg) into neonatal
female mice from P1 to P5 (Ji et al., 2009). Routine ovariectomy
was performed on 8-week-old mice exposed to oil or DES from P1
to P5. The mice were allowed to recover for 2 weeks, followed by
one subcutaneous injection of either 100 l corn oil, 100 l DES
(20 g) or 100 l E2 (100 ng) (Sigma). Uteri were harvested for
fixation or RNA extraction 24 hours later.
Separation of UE cells
To isolate UE cells, we followed a protocol described previously
with slight modifications (Bigsby et al., 1986). Briefly, whole uteri
were dissected from P5 mice of the same treatment group and
pooled accordingly. Each uterine horn was cut into 3-4 mm pieces
and rinsed in Ca2+-free, Mg2+-free Hank’s balanced salt solution
(HBSS). Tissues were digested in 1% trypsin in HBSS at 4°C for 1
hour on a rotating platform. An equal volume of 5 mg/ml bovine
serum albumin (BSA) was added to stop the digestion. Gentle
pressure was applied along each piece with tweezers to squeeze
out the epithelia, which were transferred to 1.5-ml tubes by
pipetting. The epithelial cells were collected by low-speed
centrifugation. The remaining uterine tissue containing mostly
mesenchymal cells was transferred to 1.5-ml tubes and spun down.
RNA extraction and quantitative RT-PCR
Total RNA was isolated from the cell and tissue pellets with RNA
Stat-60 (Tel-Test, Friendswood, TX) following the manufacturer’s
instructions. Primer design, reverse transcription and real-time RT-
PCR were performed as previously described (Yin et al., 2008).
Student’s t-test was performed on biological triplicates and P<0.05
was considered statistically significant.
cDNA microarray and data analysis
Oil- or DES-treated P5 mice were harvested and the epithelia
separated from the mesenchyme. UE or UM tissues from three or
four animals of the same treatment group were pooled together
and RNA isolated to make one sample. Three RNA samples of each
tissue per treatment group were used for microarray analysis for
statistical purposes. Total RNA was cleaned using RNeasy Kit
(Qiagen, Valencia, CA) and 1 g purified RNA of each sample was
submitted to the Genome Technology Access Center at Washington
University School of Medicine. A total of 12 samples were randomly
applied to two Illumina MouseWG-6 BeadChips, hybridized and
imaged as per the manufacturer’s instructions. An average
normalization algorithm was used to normalize the signals and is
available upon request. Normalized signals were first filtered by
intensity to eliminate genes that were not expressed in any of the
four groups. Average signal intensity and fold-change for each probe
were then calculated (oil UE versus DES UE and oil UM versus
DES UM). The remaining data were further filtered to eliminate
those significantly changed by no more than twofold (P<0.05 was
considered significant) in any of the two comparisons. Hierarchical
clustering was performed on DRGs using the program Cluster 3.0
and the output dendrograms and heatmaps were visualized using
the program Treeview (Eisen et al., 1998). Star Glyph was plotted
in Microsoft Excel 2007. The data discussed in this paper have been
deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 2002)
and are accessible through GEO series accession number GSE37969
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?accGSE37969).
Western blot, immunohistochemistry, immunofluorescence and
Oil-Red O staining
Western blot, immunohistochemistry and immunofluorescence
were performed as described previously (Yin et al., 2008; Yin et al.,
2011). Antibodies and dilutions used were: 1:100
(immunohistochemistry) and 1:1000 (western blot) for PPAR (Cell
Signaling); 1:5000 (western blot) for GAPDH (Cell Signaling); 1:200
(immunofluorescence) for KLF4 (Santa Cruz Biotechnology); 1:100
(immunofluorescence) for G6PD and GLUT1 (generous gifts from
Kelle Moley, Washington University, St Louis, MO); 1:100 for HK2
(Cell Signaling); 1:1000 for Alexa-Fluor-594-conjugated goat anti-
rabbit (Invitrogen) and 1:5000 for HRP-conjugated goat anti-rabbit
secondary antibodies. For ORO staining, tissues were fixed in 4%
paraformaldehyde briefly, washed through a series of Tissue-Tek
optimal cutting temperature compound (OCT)-sucrose solutions,
and embedded in OCT Slides of 10-m frozen sections were
washed in water once, twice in 100% propylene glycol (Sigma) and
then stained in 0.7% ORO in propylene glycol for 7 minutes with
agitation at 60°C. Slides were then washed in 85% propylene glycol
briefly, rinsed in water and mounted with glycerin jelly.
Transmission electron microscopy
Uterus was fixed in 4% PFA and 2.5% glutaraldehyde, contrasted
with osmium tetroxide and embedded in resin. Ultrathin sections
were cut and examined under a Hitachi H7600 TEM system. To
count lipid droplets in each image, a line was drawn along the
basement membrane of the UE cells, its length measured. All
TRANSLATIONAL IMPACT
Clinical issue
In utero exposure to endocrine-disrupting chemicals (EDCs) is associated with
reproductive tract malformations, cancer, obesity and type 2 diabetes later in
life. Diethylstilbestrol (DES), a synthetic estrogen that was prescribed in the
1940s-1970s to prevent miscarriage, is a prototype EDC that causes
reproductive tract malformations and cancers in exposed populations. An
established mouse model has shown that neonatal DES exposure results in
uterine malformations, uterine adenocarcinoma and weight gain in adult mice.
However, the molecular mechanisms underlying DES toxicity have been
elusive. 
Results
The authors use a genetic profiling approach to uncover genes regulated by
DES in the mouse uterus and identify several new targets, including genes
involved in lipid and glucose metabolism. They show that DES activates the
transcriptional program for adipogenesis in the uterine epithelium, and
identify peroxisome proliferator-activated receptor- (Ppar) as a crucial player
in this process. Furthermore, they found that DES exposure altered glucose
metabolism in the uterine epithelium. Finally, the authors show that neonatal
DES treatment elicits permanent metabolic changes in the uterus that are still
detectable in adult mice.
Implications and future directions 
These findings indicate that DES exposure causes marked metabolic changes
in uterine epithelial cells, some of which persist into adulthood, providing new
clues regarding how EDCs might cause reproductive problems. In addition to
affecting uterine epithelium, DES also induces PPAR expression in neonatal
adipose tissue; the authors propose that in utero exposure to other EDCs might
contribute to adult obesity via activation of the adipogenic program through
similar molecular mechanisms. Future studies that investigate molecular
changes in adipose tissues in DES-exposed mice will further understanding on
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droplets in the included UE cells were counted. The average
number of lipid droplets per length was calculated from images
(five images per sample, n3 per treatment). Student’s t-tests were
performed for statistical analysis.
Glucose uptake assay
Glucose uptake assays were performed on freshly isolated UE cells
from oil- or DES-treated mice on P5 following previously described
methods with modifications (Frolova et al., 2009; Keawpradub and
Purintrapiban, 2009). Briefly, enriched UE cells were washed and
incubated in 1× Krebs-Ringer buffer (125 mM NaCl, 4.7 mM KCl,
2 mM CaCl2, 2.4 mM MgSO4, 25 mM HEPES, 0.5% BSA and 1.2
mM K2HPO4) containing 1 mM glucose for 10 minutes. Cells were
spun down then resuspended in 1 ml 1× Krebs-Ringer buffer
containing 1 mM glucose and 0.1 Ci/ml 2-deoxy-D-glucose, [1-
14C] (MP Biomedicals) for exactly 1 minute. Cytochalasin B (5 l
of 50 mM stock solution) was added to the reaction to stop glucose
uptake. Cell pellets were washed and lysed in 0.05 N NaOH.
Radioactivity taken up by the cells was determined using a
scintillation counter. Aliquots from each sample were used to
determine the protein concentration using the Bradford assay.
Reactions were normalized to total protein, and glucose uptake
expressed as DPM/mg protein/10 minutes. Three pools of UE cells
receiving control or hormone treatment were used for statistical
analysis.
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